Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 18, 2018 - The FDA announced that serious cases of neural tube birth defects have been reported in babies born to women treated with dolutegravir.
Download PDF
Return to publications
